Home > 暂无记录 暂无记录 公司动态

公司动态


  • Lapatinib Ditosylate EY0418

    Lapatinib Ditosylate is the xylenesulfonic acid salt form of lapatinib (GW-572016), a small-molecule dual inhibitor of EGFR and ErbB2 receptor kinase activities. Lapatinib ditosylate (甲苯磺酸拉帕替尼; GW-572016 ditosylate) 是EGFR和ErbB2抑制剂,IC50分别为10.8和9.2 nM。

    More
  • (+)-JQ1 EY0384

    (+)-JQ1, an active enantiomer of JQ1, is a potent, highly specific and Kac-competitive inhibitor of bromodomain and extraterminal domain (BET) proteins, blocks BRD4 resulting in inhibition of c-Myc expression and tumor growth. (+)-JQ1是一种BET bromodomain抑制剂,作用于BRD4(2),IC50为33 nM,结合到BET家族的所有Bromodomain结构域,而不结合到BET家族以外的Bromodomain结构域。

    More
  • Rocilinostat EY0391

    Ricolinostat (ACY-1215) is an oral, first-in-class, selective inhibitor of HDAC6, and inhibits tubulin deacetylase. Rocilinostat (ACY-1215)是高效HDAC6抑制剂,IC50为5 nM,比对HDAC1/2/3的抑制性高10倍以上,对HDAC8有微弱活性,对HDAC4/5/7/9/11,Sirtuin1和Sirtuin2活性最低。

    More
  • Kartogenin EY0396

    Kartogenin (KGN), a small molecular compound, can induce bone marrow-derived mesenchymal stem cells (BMSCs) into chondrocytes. Kartogenin是针对软骨形成的小分子激动剂,促进软骨细胞分化(EC50为100nM),结合filamin A,并阻止其与转录因子CBFβ)的相互作用。

    More
  • KX2-391 EY0397

    KX2-391 (KX-01), the first peptidomimetic Src kinase inhibitor, is a synthetic, orally bioavailable inhibitor that has tubulin polymerization inhibition as a second mechanism of action, and is currently in Phase-2 testing for solid tumors. KX2-391 (KX01)是第一个进入临床的拟肽类Src抑制剂,靶向Src的多肽底物结合位点,对多种癌细胞株GI50为9-60 nM。

    More
  • Current page312, Total Pages415, Total Record2075 First Prev 310311312313314 Next Last Goto